SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc. announced today the appointment of Kathleen LaPorte as Chief Executive Officer. Since July 2014, she has served as the company’s Chief Business Officer. Ms. LaPorte has a solid track record of leading life sciences companies with revolutionary technologies to success. Nodality is a privately held life sciences company whose novel multi-parametric flow cytometry platform – Single Cell Network Profiling (SCNP) – reveals complex biology at the single-cell level, providing unique insights to address the most pressing challenges in drug discovery and development.
Help employers find you! Check out all the jobs and post your resume.
